Replies to post #323908 on Avid Bioservices Inc (CDMO)

[biopharm]

Exosomes $200 Billion NO BULL per Jay Flatley and PS Targeting IP patent holder of these IP assets, Peregrine Pharmaceuticals...now CDMO has to get CEO Roger Lias off his behind and realize his Fiduciary Duties to the shareholders

If a test can detect Stage 1 cancer in addition to the tissue of origin, Flatley said in Jan. 2016 presentation the market could be worth a staggering $100 billion to $200 billion.
...
...

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=128932052